Psychedelic Business Spotlight: September 24, 2021
Business, Stock Reports
This week in psychedelic business news: two patents may revolutionize the medical application of psychedelic compounds; DMT and ibogaine clinical trials show promise; and stock news for psychedelic investors.
Trackbacks & Pingbacks
[…] supervised, licensed facilities.” In the U.S. cityscape, liberal strongholds Denver, Detroit, and Seattle have also passed legislation legalizing or decriminalizing natural psychedelics, like fungi-derived […]
Leave a Reply
Want to join the discussion?Feel free to contribute!